Top Companies in the Plasma Fraction Market
- Baxter International
Baxter International is a global healthcare company that specializes in the development and production of plasma-based therapies, including treatments for hemophilia, immune deficiencies, and other conditions requiring plasma-derived therapies. Their products are sold worldwide, catering to diverse medical needs. - Bayer
Bayer is a multinational pharmaceutical and life sciences company that produces plasma-derived products as part of its extensive healthcare portfolio. Bayer’s offerings focus on treating rare diseases and chronic conditions using plasma fractionation technology. - Biotest
Biotest is a global biotech company focused on the development, production, and commercialization of plasma-based therapeutics. It specializes in immunology, hematology, and intensive care medicine, offering a wide range of plasma-derived products. - BPL (Bio Products Laboratory)
BPL is a leading provider of plasma-derived therapies, specializing in the treatment of rare and chronic diseases, including hemophilia and immune deficiencies. The company is renowned for its commitment to high-quality products and innovation in the plasma fraction market. - CBPO (China Biologic Products, Inc.)
CBPO is a major player in the plasma fraction market, known for its production of high-quality human plasma-derived products. It provides treatments for immune deficiencies, bleeding disorders, and other therapeutic areas in China and globally. - CSL Behring
CSL Behring, a division of CSL Limited, is a global leader in the development and production of human plasma-based therapies. The company focuses on a range of conditions such as hemophilia, immune deficiencies, and bleeding disorders, providing life-saving treatments worldwide. - Fusion Healthcare
Fusion Healthcare develops and manufactures plasma-derived therapies, focusing on providing advanced medical treatments to address immunological and hematological disorders. The company is known for its high-quality products and global reach. - Grifols
Grifols is a Spanish multinational corporation that specializes in the development of plasma-derived medicines. It is one of the largest players in the plasma fraction market, offering therapies for diseases such as hemophilia, immune deficiencies, and other chronic conditions. - Kedrion Biopharma Inc.
Kedrion Biopharma is a global biopharmaceutical company that focuses on the development, production, and distribution of plasma-derived therapies. Their product portfolio includes treatments for bleeding disorders and immune deficiencies, contributing to the advancement of plasma fractionation. - KM Biologics
KM Biologics, part of the Japan-based KM Group, focuses on producing plasma-derived medicines, including immunoglobulins and coagulation factors. The company is dedicated to expanding its presence in the global plasma fraction market. - LBF USA
LBF USA is a key player in the plasma fraction market, specializing in the development and distribution of plasma-derived products. Their offerings are critical for the treatment of a wide range of diseases, especially those related to immune and bleeding disorders. - LFB Group
LFB Group is a French biotechnology company that develops and manufactures plasma-derived therapeutics. The company’s products treat various health conditions, including hemophilia, immune deficiencies, and other serious illnesses. - Nanyue Bio
Nanyue Bio is a leading Chinese biopharmaceutical company that focuses on the production of plasma-derived products. Their range of therapies addresses conditions such as immune deficiencies and bleeding disorders, contributing to the advancement of the global plasma fraction market. - Octopharma
Octopharma is a Swiss-based company specializing in the development of human plasma-derived therapies. Their product range includes immunoglobulins, clotting factors, and albumin, offering life-saving treatments for a variety of diseases worldwide. - RAAS (Rafael Advanced Defense Systems)
RAAS is involved in the plasma fraction market with a focus on producing high-quality plasma-derived treatments. Their products are essential for treating chronic and rare diseases, especially those related to bleeding and immune deficiencies. - Takeda Pharmaceuticals
Takeda Pharmaceuticals is a global biopharmaceutical company that produces a broad range of plasma-derived therapies. The company’s portfolio includes treatments for hemophilia, immune system disorders, and other plasma-related diseases, expanding its footprint in the global market. - Tiantan Bio
Tiantan Bio is a Chinese biopharmaceutical company known for producing plasma-derived products for the treatment of chronic diseases. The company is expanding its global presence with a focus on quality and innovation in plasma fractionation. - Weiguang Bio
Weiguang Bio is a Chinese biotechnology company that focuses on plasma fractionation and the development of plasma-derived therapies. Their products serve critical therapeutic needs in immunology and hematology, playing a significant role in the plasma fraction market.